Omnium News
ContestedLive story

Does taking Tylenol during pregnancy increase the risk of autism in children?

Current evidence does not establish that taking Tylenol during pregnancy causes autism, although some observational studies have reported associations that remain under scientific investigation.

Where the claims stand

1 corroborated2 supported

This story tracks the evidence regarding whether prenatal exposure to acetaminophen (the active ingredient in Tylenol) causes autism spectrum disorder. The question has received substantial public attention due to observational epidemiology studies, professional medical guidance, and litigation. We track what primary research, official guidance, and court proceedings establish separately.

Sign in to follow

We'll only notify you when something material changes.

Additional information

Status

as of July 8, 2026
Contested

Multiple observational studies have reported statistical associations between prenatal acetaminophen exposure and later neurodevelopmental outcomes, including autism spectrum disorder. However, these studies face important limitations, including confounding, exposure measurement uncertainty, and inability to establish causation. Large sibling-controlled analyses have not found increased risk after accounting for familial factors. Regulatory agencies and major medical organizations have not concluded that a causal relationship has been established. Litigation concerning these claims has proceeded independently of the scientific evidence and has included federal court rulings regarding the admissibility of expert testimony.

Confidence — current state

The strongest available evidence consists primarily of observational cohort and case-control studies, systematic reviews, and meta-analyses. These can identify statistical associations but are generally limited in their ability to determine causation because treatment is not randomly assigned and important confounding factors may remain. Sibling-controlled studies that better account for shared familial factors have not found increased autism or ADHD risk. Scientific reviews continue to evaluate whether observed associations reflect a causal effect, underlying maternal illness, genetic factors, indication for medication use, or other sources of bias.

This is our best read given the published evidence we have reviewed — not a claim of absolute truth.

Open questions

  • To what extent are observed associations explained by confounding — when a hidden third factor distorts an experiment's results?

    Maternal illness, fever, genetics, and other factors may influence both acetaminophen use and child neurodevelopment.

  • Can future studies better measure dose, timing, and duration of prenatal exposure?

    Many existing studies rely on self-reported medication use or incomplete exposure records.

  • Are there biological mechanisms that independently support causation?

    Mechanistic evidence could strengthen or weaken causal interpretations of observational findings.

What would change our mind

  • Multiple independent studies using methods that substantially reduce confounding and consistently demonstrate a causal relationship.
  • New primary evidence that explains previously observed associations through measured confounding or bias.
  • Updated systematic reviews or regulatory assessments concluding that causation has or has not been established based on new evidence.

Claims & evidence

Each claim is tracked separately — not a single verdict.

What this doesn’t establish

Claims commonly associated with this story that the available evidence does not establish. Confirming a narrow fact here is not confirmation of the broader narrative around it. As such, these claims are not included in the claims bar above.

  • The existence of lawsuits establishes that Tylenol causes autism.

    Contradicted
    Evidence basisCourt filing · single source

  • Current evidence establishes that acetaminophen carries no possible neurodevelopmental risk under any circumstance during pregnancy.

    Unverified
    Evidence basisPeer-reviewed · independently corroborated

How we got here

10 updates · append-only
  1. New evidence

    ACOG practice advisory: no causal link; acetaminophen remains first-line

    ACOG reaffirmed acetaminophen as the analgesic and antipyretic of choice in pregnancy and stated that the current weight of evidence does not support a causal link to neurodevelopmental disorders.

    What changed

    • Medical society read: 2021 response to consensus statement 2025 practice advisory: no causal link supported
  2. New evidence

    FDA initiates acetaminophen pregnancy label change; causation not established

    FDA announced a process to update acetaminophen labeling regarding a possible association with autism and ADHD, while stating that a causal relationship has not been established and that contrary studies exist.

    What changed

    • FDA position: Earlier inconclusive safety reviews 2025: possible association noted; causation not established
  3. New evidence

    Swedish sibling-controlled study finds no autism or ADHD association

    Ahlqvist and colleagues analyzed about 2.5 million Swedish children. Crude models showed small associations, but sibling-control analyses found no increased risk of autism, ADHD, or intellectual disability, suggesting earlier associations may reflect familial confounding.

    What changed

    • Confounding-control evidence: Associations reported; familial confounding unresolved Large sibling-controlled null findings published
  4. New evidence

    Federal MDL excludes general-causation expert testimony

    A federal district court excluded plaintiffs' general-causation experts under Rule 702 in the acetaminophen autism/ADHD multidistrict litigation.

    What changed

    • Litigation evidence state: Claims filed; experts proffered Daubert order excludes general-causation experts
  5. New evidence

    ACOG responds that causation is not established

    Responding to the Nature Reviews Endocrinology consensus statement, ACOG stated there is no clear evidence of a direct relationship between prudent acetaminophen use during pregnancy and fetal developmental problems.

    What changed

    • Medical society read: Consensus call for precaution ACOG: causation not established
  6. New evidence

    Nature Reviews Endocrinology publishes precautionary consensus statement

    A consensus statement by Bauer and colleagues summarized observational and experimental evidence on prenatal paracetamol exposure and called for precautionary action, including minimizing use unless medically indicated.

    What changed

    • Scientific debate: Association studies and reviews Consensus call for precautionary action published
  7. New evidence

    JAMA Psychiatry publishes cord-biomarker association study

    A peer-reviewed observational study reported associations between higher cord plasma acetaminophen biomarkers and increased ADHD and autism-related outcomes.

    What changed

    • Observational evidence: Self-report and registry-based cohorts Major cord-biomarker association study published
  8. New evidence

    Meta-analysis pools observational associations for ADHD and ASD

    Masarwa and colleagues summarized cohort evidence associating prenatal acetaminophen with higher pooled risk of ADHD and ASD, while cautioning that the data remain observational and susceptible to bias.

    What changed

    • Evidence synthesis: Individual cohort findings Meta-analysis reports pooled ADHD and ASD associations
  9. New evidence

    Danish cohort study links prenatal acetaminophen to ASD with hyperkinetic symptoms

    Liew and colleagues reported the first large prospective cohort analysis of prenatal acetaminophen and diagnosed ASD, finding an association for ASD with hyperkinetic symptoms but not for other ASD cases.

    What changed

    • Observational evidence: Ecological hypotheses First large prospective ASD diagnosis cohort published
  10. New evidence

    Ecological study hypothesizes prenatal/perinatal paracetamol–autism link

    Bauer and Kriebel reported country- and state-level correlations between indicators of prenatal and perinatal paracetamol exposure and autism/ASD prevalence, calling for formal epidemiologic study while noting ecological designs cannot establish causality.

    What changed

    • Observational evidence: No major published acetaminophen–ASD hypothesis paper Ecological correlation hypothesis published

Suggest a source

Point us to a primary source or a publisher correction. Sign in to submit — every suggestion is reviewed by a human before anything changes.

Confidence last reviewed July 8, 2026. Updates are append-only; nothing here is edited silently.